Optos, PLC
The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes
Inclusion/Exclusion Criteria Inclusion Criteria for Retinal Disease Group 1. Participants 22 years of age or older on the date of informed consent 2. Participants able to understand the written informed consent and willing to participate as evidenced by signing the informed consent 3. BCVA 20/400 or better in the study eye 4. Participants presenting at the site with retinal disease 5. Diagnosis of some type of retinal pathology by investigator, may include, but not limited to: Macular Degeneration (including participants with drusen and geographic atrophy and choroidal neovascularization), Di…
A10900 is an optical coherence tomography device
Arctuva estimate
Verify or correct the compensation shown for this listing.